Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Who's Afraid Of A Tweet And A Pin? Strategies To Start Engaging Online

Executive Summary

Lubna Ahmed explores how pharma can benefit from using social media, where the industry is at now and the different ways it could make the most out of the tools that have become centerpieces of our world's communication.

Advertisement

Related Content

Social Media/Mobile Health Data: What's It Good For?
Boehringer out tweets, pins, posts and shares its peers
Biosimilars, social media among 2015 expected FDA guidances
Surviving a Scandal: How to Expect the Unexpected
Pharma ears burn as they listen in on social media

Topics

Advertisement
UsernamePublicRestriction

Register

SC065067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel